decaro

NMTR: an explosive biotech microcap

NASDAQ:NMTR   None
NMTR had an incredible run over the past month. But it appears that it has been rejected at resistance, and will retrace fib levels back toward $1.00 before exiting this wedge.

A defined risk strategy here is to buy the $1.00 puts, continue rolling them out, and then within the next month add the $1 calls to form a long straddle. Be careful as liquidity is low.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。